AIwithCare features a software platform that uses generative AI to screen patients for clinical trial eligibility.
Drugs are man-made miracles. They enhance our health, cure diseases, and extend our lives. However, drug development is not easy. It is a remarkably long, expensive, and complex process. On average, ...
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers who created a Retrieval-Augmented Generation (RAG)–based AI tool that greatly outperforms manual review ...
BOWIE, Md.--(BUSINESS WIRE)--Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the launch of Clinical Research Patient Finder, an ...
Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that U.K. participants can search for possible trials to join. PKB users ...
Forbes contributors publish independent expert analyses and insights. Tor Constantino is an ex-reporter, turned AI consultant & tech writer. The cost to create an innovative drug within the U.S.
SAN JOSE, Calif.--(BUSINESS WIRE)--Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the first patient treated as part of the AAA-SHAPE Pivotal ...